PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Illumina stock at 6.37%, United Therapeutics at 5.86%, Biogen at 4.97%, Incyte at 4.76%, and Gilead Sciences at 4.55%.

Total Holdings

Top 10 Percentage

46.45%

Asset Class

Equity

ETF Category

Health

Assets

259.01M

PE Ratio

19.24

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ILMN	Illumina, Inc.	6.37%	104,158
2	UTHR	United Therapeutics Corporation	5.86%	27,038
3	BIIB	Biogen Inc.	4.97%	65,601
4	INCY	Incyte Corporation	4.76%	126,679
5	GILD	Gilead Sciences, Inc.	4.55%	86,702
6	ALNY	Alnylam Pharmaceuticals, Inc.	4.52%	38,458
7	AMGN	Amgen Inc.	4.34%	33,435
8	REGN	Regeneron Pharmaceuticals, Inc.	3.97%	16,576
9	VCYT	Veracyte, Inc.	3.62%	195,637
10	CPRX	Catalyst Pharmaceuticals, Inc.	3.48%	288,645
11	TGTX	TG Therapeutics, Inc.	3.43%	228,853
12	ARWR	Arrowhead Pharmaceuticals, Inc.	3.34%	109,664
13	RPRX	Royalty Pharma plc	3.23%	153,795
14	BCRX	BioCryst Pharmaceuticals, Inc.	3.22%	917,520
15	NBIX	Neurocrine Biosciences, Inc.	3.21%	53,314
16	CDNA	CareDx, Inc.	3.17%	362,717
17	PTGX	Protagonist Therapeutics, Inc.	3.09%	79,897
18	EXEL	Exelixis, Inc.	3.07%	154,680
19	PTCT	PTC Therapeutics, Inc.	2.77%	101,221
20	HALO	Halozyme Therapeutics, Inc.	2.61%	99,238
21	RGEN	Repligen Corporation	2.45%	51,847
22	IONS	Ionis Pharmaceuticals, Inc.	2.44%	81,712
23	VCEL	Vericel Corporation	2.41%	182,544
24	TECH	Bio-Techne Corporation	2.38%	121,220
25	ACAD	ACADIA Pharmaceuticals Inc.	2.37%	283,949

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of May 28, 2026